Sangamo Therapeutics
SGMO
#9099
Rank
$0.12 B
Marketcap
$0.36
Share price
-7.64%
Change (1 day)
-70.95%
Change (1 year)

Sangamo Therapeutics (SGMO) - P/B ratio

P/B ratio as of February 2026 : 19.4

According to Sangamo Therapeutics 's latest financial reports the company has a price-to-book ratio of 3.68685.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Sangamo Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-3123.60.78%
2024-12-3123.51917.96%
2023-12-311.16-33.37%
2022-12-311.74-40.07%
2021-12-312.91-34.41%
2020-12-314.4497.84%
2019-12-312.24-29.78%
2018-12-313.19-56.7%
2017-12-317.38366.44%
2016-12-311.58-52.62%
2015-12-313.34-34.34%
2014-12-315.08-28.44%
2013-12-317.1044.56%
2012-12-314.91164.22%
2011-12-311.86-65.49%
2010-12-315.3945.24%
2009-12-313.7144.14%
2008-12-312.57-64.63%
2007-12-317.2853.27%
2006-12-314.7545.76%
2005-12-313.26-30.43%
2004-12-314.6853.23%
2003-12-313.06122.63%
2002-12-311.37

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.13-63.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
20.5 5.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.49-92.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
1.22-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
8.46-56.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.69-70.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
199 923.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.83-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA